Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone app tested as a tool for measuring spine curvature

NCT ID NCT05295550

Knowledge-focused Sponsor: Gaziantep Islam Science and Technology University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether a smartphone inclinometer app can reliably measure the forward curve of the upper spine (thoracic kyphosis) compared to a standard flexible ruler. Sixty adults with at least a 30-degree curve were measured by two different raters. The goal was to see if the app gives consistent results, which could make monitoring easier and more accessible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Sep 2021

Finished

Dec 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * over 30 degree toracic kyphosis, * 18-30 age year old, * individuals to willing participate in the study Exclusion Criteria: * Skolyoz (Cobb angle 10\< ), * rigid thoracic kyphosis, * congenital spine disease, * training with professional sports

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease Scheuermann disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Disorder Kyphosis deformity of thoracic spine

Contacts and locations

Locations

  • Hasan Kalyoncu Üniversitesi

    Şehitkamil, Gazi̇antep, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.